Santamaría, C., Chillón, M. C., García-Sanz, R., Balanzategui, A., Sarasquete, M. E., Alcoceba, M., Ramos, F., Bernal, T., Queizán, J. A., Peñarrubia, M. J., Giraldo, P., San Miguel, J. F. and Gonzalez, M. (2008) “The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia”, Haematologica. Pavia, Italy, 93(12), pp. 1797-1805. doi: 10.3324/haematol.13214.